Levin was previously group president of Nypro Healthcare, serving the drug delivery, diagnostics, and surgical markets.
“Mott’s customers are seeking ever finer and more uniform filtration and separation capabilities from products that will withstand harsh environments and provide extended service life,” said David Gordon, chairman of Mott’s board of directors. “Boris’s background in manufacturing for the medical industry, and his otherwise strong combination of academic, technical, and business credentials are ideal to lead Mott as it increasingly relies on specialised engineering and science to produce value-add products.”
